Glucocorticoid
MIS-C outcomes with glucocorticoids alone similar to IVIG, combination therapy
Glucocorticoids alone demonstrate similar recovery rates as intravenous immunoglobin, or combination therapy with both, in patients with multisystem inflammatory syndrome in children, according to data published in The Lancet Rheumatology.
Trabecular bone score less useful bone strength biomarker than BMD for older adults
Antiresorptive medications such as oral bisphosphonates have a minimal effect on change in lumbar spine trabecular bone score among older adults, according to a study published in The Journal of Bone and Mineral Research.
Consensus statement on thyroid eye disease focuses on new therapies, individualized care
Individualized care and patient satisfaction are among the areas of emphasis in a new consensus statement on management of thyroid eye disease.
Sarilumab, tapered glucocorticoids improve steroid-resistant polymyalgia rheumatica
PHILADELPHIA — Patients with steroid-resistant polymyalgia rheumatica who received sarilumab and tapered glucocorticoids achieved higher remission rates vs. glucocorticoid taper alone, according to data presented at ACR Convergence 2022.
Bone-safe glucocorticoid dose ‘hard to find’ in rheumatic, musculoskeletal diseases
PHILADELPHIA — A daily glucocorticoid dose higher than 2.5 mg may lead to irreversible bone mineral density loss regardless of intervention with osteoporosis medications, according to data presented at ACR Convergence 2022.
Avacopan, rituximab allow for reduced glucocorticoid use in ANCA-associated vasculitis
SAN DIEGO — In patients with ANCA-associated vasculitis, avacopan and rituximab may offer an alternative to glucocorticoids-based management, according to a presenter at the Congress of Clinical Rheumatology West.
Physical Therapy Awareness Month shines light on therapy for patients with osteoarthritis
October is Physical Therapy Awareness month, and the role of physical therapy in the management of rheumatic diseases, specifically osteoarthritis, is being highlighted in research as well as on social media.
COVID-19 vaccines 87% effective at preventing hospitalization in immunosuppressed patients
Three doses of either the BNT162b2 or mRNA-1273 vaccine are 87% effective at preventing hospitalization due to COVID-19 among patients taking immunosuppressive drugs, according to data published in The Lancet Rheumatology.
‘Our friend and our enemy’: Rheumatologists continue to grapple with steroids
The movement away from long-term steroid use has reached all corners of rheumatology, and for good reason: Extended use of glucocorticoids can be associated with a raft of adverse outcomes.
ACR: Patients on long-term glucocorticoids should receive oral bisphosphonates
Patients receiving long-term glucocorticoids should use oral bisphosphonates to reduce the risk for bone loss and fracture, according to new guidelines currently under peer review from the American College of Rheumatology.